ChiCTR2500099869 版本V1.1 版本创建时间2025/06/16 16:14:33 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500099869 

最近更新日期:

Date of Last Refreshed on:

2025-03-31 14:54:45 

注册时间:

Date of Registration:

2025-03-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

住院青少年非自杀性自伤行为的量表研发及信效度检验

Public title:

Development and Validation of a Scale for Non-Suicidal Self-Injury Behaviors in Hospitalized Adolescents.

注册题目简写:

English Acronym:

研究课题的正式科学名称:

住院青少年非自杀性自伤行为的量表研发及信效度检验

Scientific title:

Development and Validation of a Scale for Non-Suicidal Self-Injury Behaviors in Hospitalized Adolescents.

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王涌 

研究负责人:

王涌 

Applicant:

Wang Yong 

Study leader:

Wang Yong 

申请注册联系人电话:

Applicant telephone:

+86 13621201192

研究负责人电话:

Study leader's
telephone:

+86 10 61955512

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangyong751006@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangyong751006@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区花园北路51号

研究负责人通讯地址:

北京市海淀区花园北路51号

Applicant address:

No.51 Huayuan North Road, Haidian District, Beijing

Study leader's address:

No.51 Huayuan North Road, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学第六医院

Applicant's institution:

Peking University Sixth Hospital

研究负责人所在单位:

北京大学第六医院(精神卫生研究所)

Affiliation of the Leader:

Peking University Sixth Hospital ( Institute of Mental Health )

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

( 2025 )伦审第(37 )号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学第六医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Peking University Sixth Hospital (Institute of Mental Health)

伦理委员会批准日期:

Date of approved by ethic committee:

2025-02-19 00:00:00

伦理委员会联系人:

徐文静

Contact Name of the ethic committee:

Xu Wenjing

伦理委员会联系地址:

北京市海淀区花园北路51号

Contact Address of the ethic committee:

No.51 Huayuan North Road, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 62723769

伦理委员会联系人邮箱:

Contact email of the ethic committee:

ethics_pku6@163.com

研究实施负责(组长)单位:

北京大学第六医院(精神卫生研究所)

Primary sponsor:

Peking University Sixth Hospital ( Institute of Mental Health )

研究实施负责(组长)单位地址:

北京市海淀区花园北路51号

Primary sponsor's address:

No.51 Huayuan North Road, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第六医院(精神卫生研究所)

具体地址:

北京市海淀区花园北路51号

Institution
hospital:

Peking University Sixth Hospital ( Institute of Mental Health )

Address:

No.51 Huayuan North Road, Haidian District, Beijing

经费或物资来源:

北京研究型病房卓越临床研究计划

Source(s) of funding:

Beijing Research Ward Excellence Program,BRWEP

研究疾病:

非自杀性自伤行为  

Target disease:

Non-suicidal Self-injury, NSSI

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

随着青少年心理健康问题的日益增加,非自杀性自伤行为(NSSI)成为一个重要的公共卫生问题,尤其是在住院青少年中。现有的筛查工具未能满足这一特殊群体的评估需求。本研究旨在开发一套针对住院青少年的NSSI评估量表,提升评估的准确性和临床适用性。通过关注情绪调节机制和住院环境特有的因素,该工具将改善早期识别和干预效果,减少NSSI的发生,减轻照护者负担,提升青少年生活质量。此外,本研究还将为NSSI的行为管理提供证据支持,推动青少年心理健康护理的发展。  

Objectives of Study:

With the increasing number of mental health problems among adolescents, non-suicidal self-injurious behavior (NSSI) has become an important public health issue, especially among hospitalized adolescents. Existing screening tools fail to meet the assessment needs of this specialized population. The aim of this study was to develop an NSSI assessment scale for hospitalized adolescents to improve the accuracy and clinical applicability of the assessment. By focusing on emotion regulation mechanisms and factors specific to the hospitalized setting, this tool will improve early identification and intervention outcomes, reduce the incidence of NSSI, reduce caregiver burden, and enhance adolescents' quality of life. In addition, this study will provide evidence-based support for behavioral management of NSSI and promote the development of adolescent mental health care. Translated with DeepL.com (free version)

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合精神障碍诊断与统计手册第5版(Diagnostic and Statistical Manual of Mental Disorders Fifth edition,DSM-5)中关于NSSI的建议的诊断标准,将符合下列任意一项即判定为有NSSI:过去6个月内至少出现3次NSSI其中近1个月至少出现1次;2过去12个月内至少出现5次NSSI,其中近1个月至少出现1次;
2.年龄12-17岁;
3.读写能力正常;
4.患者及监护人均知情同意参与研究。

Inclusion criteria

1.Diagnostic criteria that meet the Diagnostic and Statistical Manual of Mental Disorders Fifth edition (DSM-5) recommendations for NSSI will be determined to have an NSSI if any of the following are met: at least 3 occurrences of the NSSI in the last 6 months NSSI at least 3 times in the last 6 months, including at least 1 time in the last 1 month;2 NSSI at least 5 times in the last 12 months, including at least 1 time in the last 1 month; Translated with DeepL.com (free version);
2.Age 12-17 years;
3.Normal reading and writing ability.
4.Patients and guardians gave informed consent to participate in the study.

排除标准:

1.合并其他精神障碍性疾病或智力障碍,如自闭症、狂躁症、边缘型人格障碍等;
2.因其他疾病导致的继发抑郁障碍者;
3.合并脑器质性病变或神经系统疾病;
4.合并严重躯体疾病或心肝肺肾等脏器功能不全;
5.有成瘾史、物质滥用或依赖史;
6.前期研究参与:已经参与了本研究的初步测试或其他相关研究阶段的青少年,以避免重复数据或偏差。

Exclusion criteria:

1.Comorbidity with other psychotic disorders or intellectual disabilities, such as autism, mania, and borderline personality disorder;
2.Those with secondary depressive disorders due to other diseases;
3.Combined with organic brain lesions or neurological diseases.
4.Combined with severe physical diseases or organ dysfunction such as heart, liver, lung and kidney; Combined with addiction history, substance abuse and other diseases.
5.History of addiction, substance abuse or dependence;
6.Pre-study participation: adolescents who have already participated in the preliminary testing of this study or other related research phases to avoid duplication of data or bias.

研究实施时间:

Study execute time:

From 2024-11-01 00:00:00 To 2027-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-01 00:00:00 To 2025-08-01 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

400

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第六医院(精神卫生研究所) 

单位级别:

三级甲等 

Institution
hospital:

Peking University Sixth Hospital ( Institute of Mental Health )

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

内部一致性

指标类型:

主要指标

Outcome:

Internal consistency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

结构效度

指标类型:

次要指标

Outcome:

Construct validity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 12 years
最大 Max age 17 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF;EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-03-31 14:54:33